Close Menu

In PLoS Genetics this week, a large, international research consortium reports data from its two-stage genome-wide association study to determine whether common genetic variants modify penetrance for BRCA2 mutation carriers. First, the team genotyped nearly 600,000 SNPs from more than 800 young affected and unaffected carriers, and stratified the individuals based on their BRCA2*6174delT status.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.